001     280933
005     20250918102642.0
024 7 _ |a 10.1016/B978-0-12-815946-0.00003-X
|2 doi
037 _ _ |a DZNE-2025-01016
100 1 _ |a Pan-Montojo, F.
|b 0
245 _ _ |a The role of environmental toxins and inflammation in Parkinson's disease pathophysiology: a historical perspective and research-based evidence
260 _ _ |c 2020
|b Elsevier
295 1 0 |a Diagnosis and Management in Parkinson's Disease / Pan-Montojo, F. ; : Elsevier, 2020, ; ISBN: 9780128159460 ; doi:10.1016/B978-0-12-815946-0.00003-X
300 _ _ |a 29 - 55
336 7 _ |a BOOK_CHAPTER
|2 ORCID
336 7 _ |a Book Section
|0 7
|2 EndNote
336 7 _ |a bookPart
|2 DRIVER
336 7 _ |a INBOOK
|2 BibTeX
336 7 _ |a Output Types/Book chapter
|2 DataCite
336 7 _ |a Contribution to a book
|b contb
|m contb
|0 PUB:(DE-HGF)7
|s 1758102789_31851
|2 PUB:(DE-HGF)
520 _ _ |a Parkinson's disease (PD) was first described by the English physician James Parkinson in his work An Essay on the Shaking Palsy in 1817. This correlates well with the beginning of the industrial and chemical revolution in Europe during the late 18th and 19th centuries. This period and the time afterward are linked to the increased production and use of chemicals and pesticides. In this chapter, we review (1) the epidemiological evidence linking the appearance of PD to an increase in exposure to environmental toxins, and (2) the possible mechanisms underlying this correlation obtained from in vitro and in vivo experimental studies.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef Book
700 1 _ |a Löwenbrück, Kai
|0 P:(DE-2719)2812785
|b 1
|u dzne
700 1 _ |a Reichmann, H.
|b 2
773 _ _ |a 10.1016/B978-0-12-815946-0.00003-X
856 4 _ |u https://pub.dzne.de/record/280933/files/DZNE-2025-01016.pdf
856 4 _ |u https://pub.dzne.de/record/280933/files/DZNE-2025-01016.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:pub.dzne.de:280933
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2812785
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
920 1 _ |0 I:(DE-2719)1710012
|k AG Falkenburger
|l Translational Parkinson Research
|x 0
980 _ _ |a contb
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1710012
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21